Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Primaa logo — Primaa develops AI-based software for histological diagnoses...

Primaa

Primaa develops AI-based software for histological diagnoses, improving a vital step in the detection of cancer.

Founded 2018 France France 31 employees Venture round Total: $9.00M Health Care

General Information

Company Name Primaa
Founded Year 2018
Location France France
Employees 31
Industries Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Primaa. To contact Primaa, visit primaalab.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Primaa compare?

A PDF of Primaa and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Primaa soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Primaa

Primaa is a France-based startup founded in 2018 that specializes in the development of AI-based software for histological diagnoses. The company's slogan succinctly captures the essence of their mission, which is to improve the detection of cancer through innovative AI technology. Primaa's focus on the Health Care industry aligns with the growing trend of utilizing artificial intelligence to enhance healthcare outcomes.

The company recently secured a significant milestone with a €2.00M Seed Round investment on 11 October 2019. The investors involved in this round, including 50 Partners, Angels Santé, Pleiade Venture, Damien Guermonprez, Fonds Ambition Amorçage Angels, and Entrepreneurs Investis, represent a diverse group committed to supporting Primaa's innovative approach to cancer diagnosis and treatment.

Primaa's commitment to leveraging AI for histological and cancer diagnoses positions the company at the forefront of a transformative trend in healthcare. The recent investment signifies a vote of confidence from prominent investors and highlights the potential for Primaa to make significant strides in advancing cancer detection and patient care.

Business keywords: digital pathology, histopathology, image analysis, cancer diagnosis, healthcare AI, histological diagnoses

Services & Products

AI-based platform for automated and accurate cancer diagnosis

Target Customers

Pathologists Healthcare Institutions Clinical Researchers

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture round €7.00M 5
Elaia Swen Capital Partners ⚡ SUPER CAPITAL ⚡
Elaia, Swen Capital Partners +3
29 Oct 2025
Seed Round €2.00M 6
50 Partners Angels Santé Pleiade Venture
50 Partners, Angels Santé +4
11 Oct 2019
Non Equity Assistance Undisclosed 1
AGORANOV
AGORANOV
01 Jul 2018

Latest News

View All
Primaa raises €7M to accelerate product growth and international expansion — Tech
Primaa raises €7M to accelerate product growth and international expansion
Tech Oct 29, 2025

Primaa Alternatives & Competitors

View All Alternatives
Primaa vs
Mindpeak
Mindpeak Germany

Our mission is to enable personalised cancer treatment through AI tissue diagnostics

Series A
53 employees
AI, Biotechnology
Compare Primaa vs Mindpeak
Primaa vs
Virasoft Corporation
Virasoft Corporation United States

Connecting People. Elevating Patient Care. Complete Pathology Workflows with Integrated Digital Path...

43 employees
AI, Biotechnology
Compare Primaa vs Virasoft Corporation
Primaa vs
Exai Bio
Exai Bio United States

Delivering next-generation liquid biopsy platform for the earliest detection and most accurate cance...

22 employees
Biotechnology, Health Care
View all alternatives

FAQ About Primaa

Primaa develops AI-based software for histological diagnoses, improving a vital step in the detection of cancer.
Primaa was founded in 2018.
Primaa is headquartered in France.
Primaa operates in Health Care. Its work centres on digital pathology, histopathology, image analysis and cancer diagnosis. Its customers include Pathologists, Healthcare Institutions and Clinical Researchers.
Primaa has approximately 31 employees.
Primaa has completed 3 funding rounds, raising a total of $9.00M. The latest funding stage is Venture round.
Primaa offers: AI-based platform for automated and accurate cancer diagnosis.
Top alternatives and competitors to Primaa include Mindpeak, Virasoft Corporation, Exai Bio, Aiforia Technologies, Ibex Medical Analytics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Primaa and Mindpeak are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Primaa, https://bouncewatch.com/company/primaa, updated 29 October 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout